SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-102386
Filing Date
2020-09-04
Accepted
2020-09-04 07:12:49
Documents
11
Period of Report
2020-09-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2030109d1_6k.htm 6-K 49438
2 GRAPHIC tm2030409d1_6kimg001.jpg GRAPHIC 461693
3 GRAPHIC tm2030409d1_6kimg002.jpg GRAPHIC 658962
4 GRAPHIC tm2030409d1_6kimg003.jpg GRAPHIC 549927
5 GRAPHIC tm2030409d1_6kimg004.jpg GRAPHIC 614339
6 GRAPHIC tm2030409d1_6kimg005.jpg GRAPHIC 673359
7 GRAPHIC tm2030409d1_6kimg006.jpg GRAPHIC 687031
8 GRAPHIC tm2030409d1_6kimg007.jpg GRAPHIC 703400
9 GRAPHIC tm2030409d1_6kimg008.jpg GRAPHIC 679072
10 GRAPHIC tm2030409d1_6kimg009.jpg GRAPHIC 638583
11 GRAPHIC tm2030409d1_6kimg010.jpg GRAPHIC 185975
  Complete submission text file 0001104659-20-102386.txt   8069824
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 201160612
SIC: 2834 Pharmaceutical Preparations